genedrive plc (LON:GDR – Get Free Report) shares shot up 0.2% on Thursday . The company traded as high as GBX 1.10 and last traded at GBX 1.03. 3,438,420 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 6,745,752 shares. The stock had previously closed at GBX 1.03.
genedrive Stock Performance
The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35. The business has a 50 day moving average price of GBX 0.96 and a 200-day moving average price of GBX 0.81. The firm has a market capitalization of £11.84 million, a PE ratio of -1.28 and a beta of -0.04.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Featured Articles
- Five stocks we like better than genedrive
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Your Bank Account Is No Longer Safe
- He just nailed another gold prediction …
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
